The CCK8 assay showed that silencing LOXL2 could abrogate the proliferation enhanced by ETV4 overexpression, while overexpression of LOXL2 rescued the cell viability inhibited by ETV4 knockdown in CRC cells (Fig 5a-b and Fig.S9a-b). This evidence concerns the gene LOXL2 and colorectal carcinoma.